Company Filing History:
Years Active: 2017
Title: Aprile L Pilon-Clayton: Innovator in Nasal Rhinitis Treatment
Introduction
Aprile L Pilon-Clayton is a notable inventor based in Germantown, MD (US). She has made significant contributions to the field of medical therapeutics, particularly in the treatment of nasal conditions. Her innovative work has led to the development of a unique therapeutic approach that addresses common nasal ailments.
Latest Patents
Pilon-Clayton holds a patent for "Recombinant human CC10 and compositions thereof for use in the treatment of nasal rhinitis." This invention relates to the use of recombinant human CC10 (rhCC10), also known as recombinant human uteroglobin, as a therapeutic agent for nasal rhinitis, nasal sinusitis, chronic rhinosinusitis, and nasal polyposis. The patent outlines methods for administering rhCC10, including critical dosage ranges and the intranasal route of administration, to effectively treat these conditions. The invention also provides a composition that facilitates the safe administration of rhCC10 to humans.
Career Highlights
Pilon-Clayton is associated with Therabron Therapeutics, Inc., where she continues to advance her research and development efforts. Her work at the company focuses on innovative solutions for respiratory conditions, showcasing her commitment to improving patient outcomes through scientific advancements.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Aprile L Pilon-Clayton's contributions to the field of nasal therapeutics exemplify her dedication to innovation and patient care. Her patent for recombinant human CC10 represents a significant advancement in the treatment of nasal conditions, highlighting her role as a leading inventor in this area.